(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TERAPIA CONTRA O CÂNCER COM CÉLULAS IMUNITÁRIAS ANTI-CD33

ArquivadaInvention PatentPCT · IB2019001194

Application data

Number

112021008041

Type

Invention Patent

Filing

11/07/2019

Publication

08/10/2021

PCT

IB2019001194

Progress at the INPI

  1. Filing11/07/19
  2. Publication08/10/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 11/07/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 05/02/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

CRISPR THERAPEUTICS AG

CH

See this company's full portfolio

Inventors

D. K. (pessoa física)

US

J. S. (pessoa física)

US

J. T. (pessoa física)

US

Technical data

Priority claims

US

62/756,718 · 11/07/2018

US

62/767,388 · 11/14/2018

US

62/767,395 · 11/14/2018

US

62/826,643 · 03/29/2019

US

62/826,648 · 03/29/2019

Abstract

TERAPIA CONTRA O CÂNSER COM CÉLULAS IMUNITÁRIAS ANTI-CD33.A presente invenção refere-se a métodos e composições (por exemplo, composições celulares) para o tratamento de câncer, tal como malignidades CD33+.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

05/02/2023

RPI 2730

Arquivamento - Art. 33 da LPI

#11.1

02/14/2023

RPI 2719

Notificação de entrada na fase nacional - PCT

#1.3

08/10/2021

RPI 2640

Alteração de dados cadastrais

#1.1

05/04/2021

RPI 2626

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.